Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
19 August 2022 - 4:58AM
Company announcement – No. 35 / 2022
Zealand Pharma
Increases its
Share
Capital as a
Consequence of
Exercise of
Employee
Warrants
Copenhagen, DK and Boston, MA,
August 18,
2022 – Zealand Pharma
A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a
Copenhagen-based biotechnology company focused on the discovery and
development of innovative peptide-based medicines, has increased
its share capital by a nominal amount of DKK 3,874 divided into
3,874 new shares with a nominal value of DKK 1 each. The increase
is a consequence of the exercise of warrants granted under one of
Zealand Pharma's employee warrant programs.
Employee warrant programs are part of Zealand Pharma’s incentive
scheme, and each warrant gives the owner the right to subscribe for
one new Zealand Pharma share at a pre specified price, the exercise
price, in specific predefined time periods before expiration. For a
more detailed description of Zealand Pharma’s warrant programs, see
the company’s Articles of Association, which are available on the
website: www.zealandpharma.com.
The exercise price was DKK 100.80 per share for 3,874 of the new
shares. The total proceeds to Zealand from the capital increase
amount to DKK 390,500.
The new shares give rights to dividend and other rights from the
time of the warrant holder's exercise notice. Each new share
carries one vote at Zealand Pharma’s general meetings. Zealand
Pharma has only one class of shares.
The new shares will be listed on Nasdaq Copenhagen after
registration of the capital increase with the Danish Business
Authority. Following registration of the new shares, the share
capital of Zealand Pharma will be nominal DKK 46,530,384 divided
into 46,530,384 shares with a nominal value of DKK 1 each.
The amendments to Zealand Pharma’s Articles of Association
entailed by the share capital increase have been set out below. A
full copy of the amended Articles of Association can be found at
https://www.zealandpharma.com/ and registered today with the Danish
Business Authority.
# # #
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology
company focused on the discovery and development of peptide-based
medicines. More than 10 drug candidates invented by Zealand have
advanced into clinical development, of which two have reached the
market and three candidates are in late-stage development. In
addition, license collaborations with Boehringer Ingelheim and
AstraZeneca create opportunities for more patients to potentially
benefit from Zealand-invented peptide investigational agents
currently in development.Zealand was founded in 1998 and is
headquartered in Copenhagen, Denmark, with a presence in the U.S.
that includes Boston. For more information about Zealand’s business
and activities, please visit www.zealandpharma.com.
Forward-Looking StatementThe above information
contains forward-looking statements that provide Zealand Pharma’s
expectations or forecasts of future events, including
forward-looking statements about the termination of the Company’s
ADR program. Such forward-looking statements are subject to risks,
uncertainties and inaccurate assumptions, which may cause actual
results to differ materially from expectations set forth herein and
may cause any or all of such forward-looking statements to be
incorrect. If any or all of such forward-looking statements prove
to be incorrect, our actual results could differ materially and
adversely from those anticipated or implied by such statements. All
such forward-looking statements speak only as of the date of this
release and are based on information available to Zealand Pharma as
of the date of this release. Except as required by law, the Company
assumes no obligation to update these forward-looking statements
publicly.
Contact:
Anna Krassowska,
PhDVice President, Investor Relations & Corporate
CommunicationsZealand PharmaEmail: ank@zealandpharma.comDavid Rosen
(U.S. Media)Argot PartnersEmail:
media@zealandpharma.com |
|
|
|
|
|
|
|
|
Zealand Pharma AS (NASDAQ:ZEAL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Zealand Pharma AS (NASDAQ:ZEAL)
Historical Stock Chart
From Sep 2023 to Sep 2024